CytomX Therapeutics Inc (CTMX) Stock Price, Quote, News & History

CTMXNASDAQ
$3.24
-0.09-2.70%
At close: Jul 24, 5:00 PM EST
$3.24
N/A
After Hours: 4:00 PM EST
Loading...

Key Statistics

Open
$3.34
Close
$3.24
Volume / Avg.
1.52M / 4.21M
Day Range
$3.20 - $3.38
52 Wk Range
1.72 - 8.21
Market Cap
$705.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
18.54%
Days to Cover
4.32

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-80.09M
Investing Cash Flow (TTM)
-283.12M
Financing Cash Flow (TTM)
344.93M
Free Cash Flow (TTM)
-80.19M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-18.28M

Analyst Trends and Forecast

2
Feb
8
Mar
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$381.10M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
15.04
PB Ratio (TTM)
2.27
Earnings Yield % (TTM)
-15.62%
Earnings Yield % (FWD)
-11.41%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.47

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$28.83M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.34
Close
$3.24
Volume / Avg.
1.52M / 4.21M
Day Range
$3.20 - $3.38
52 Wk Range
1.72 - 8.21
Market Cap
$705.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
18.54%
Days to Cover
4.32

About

Sector
Health Care
Industry
Biotechnology
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CytomX Therapeutics (CTMX) stock?

A

You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CytomX Therapeutics (CTMX) competitors?

A

There are no as such competitors for CytomX Therapeutics.

Q

What is the forecast, or price target, for CytomX Therapeutics (CTMX) stock?

A

CytomX Therapeutics has a consensus price target of $10.78.

Q

What is the current price for CytomX Therapeutics (CTMX)?

A

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $3.24 last updated July 24, 2026 at 4:00 PM EDT.

Q

Does CytomX Therapeutics (CTMX) pay a dividend?

A

There are no upcoming dividends for CytomX Therapeutics.

Q

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

A

CytomX Therapeutics does not have any upcoming earnings scheduled.

Q

Is CytomX Therapeutics (CTMX) going to split?

A

There is no upcoming split for CytomX Therapeutics.

Q

What sector and industry does CytomX Therapeutics (CTMX) operate in?

A

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.